Rüstem Nurten

460 total citations
28 papers, 361 citations indexed

About

Rüstem Nurten is a scholar working on Oncology, Physiology and Immunology. According to data from OpenAlex, Rüstem Nurten has authored 28 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Physiology and 10 papers in Immunology. Recurrent topics in Rüstem Nurten's work include PARP inhibition in cancer therapy (12 papers), Calcium signaling and nucleotide metabolism (10 papers) and Toxin Mechanisms and Immunotoxins (8 papers). Rüstem Nurten is often cited by papers focused on PARP inhibition in cancer therapy (12 papers), Calcium signaling and nucleotide metabolism (10 papers) and Toxin Mechanisms and Immunotoxins (8 papers). Rüstem Nurten collaborates with scholars based in Türkiye and Germany. Rüstem Nurten's co-authors include Engin Bermek, Zehra Sayers, İşıl Albeniz, Zafer Gürel, Asiye Nurten, Özlem Demir, İbrahim Kalelioğlu, Suzan Çınar, Ebru Hacıosmanoğlu and Figen Seymen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

Rüstem Nurten

28 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rüstem Nurten Türkiye 12 174 100 85 65 34 28 361
Jutta Will Germany 8 207 1.2× 62 0.6× 203 2.4× 42 0.6× 32 0.9× 11 564
Jan Pippel Germany 13 156 0.9× 76 0.8× 91 1.1× 279 4.3× 25 0.7× 15 508
Toshiaki Hosaka Japan 12 288 1.7× 72 0.7× 36 0.4× 21 0.3× 15 0.4× 29 523
Michele Fontaine United States 7 113 0.6× 114 1.1× 110 1.3× 9 0.1× 77 2.3× 9 421
Jun Kuwahara Japan 13 395 2.3× 56 0.6× 67 0.8× 12 0.2× 60 1.8× 22 572
Patrycja A. Krawczyk United Kingdom 7 461 2.6× 90 0.9× 39 0.5× 31 0.5× 77 2.3× 8 697
Hildegard I. D. Mack Germany 10 266 1.5× 24 0.2× 35 0.4× 28 0.4× 42 1.2× 18 511
Fergal O’Farrell Sweden 7 337 1.9× 72 0.7× 49 0.6× 47 0.7× 19 0.6× 12 554
Clark C. Fjeld United States 6 455 2.6× 35 0.3× 63 0.7× 17 0.3× 38 1.1× 6 575

Countries citing papers authored by Rüstem Nurten

Since Specialization
Citations

This map shows the geographic impact of Rüstem Nurten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüstem Nurten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüstem Nurten more than expected).

Fields of papers citing papers by Rüstem Nurten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüstem Nurten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüstem Nurten. The network helps show where Rüstem Nurten may publish in the future.

Co-authorship network of co-authors of Rüstem Nurten

This figure shows the co-authorship network connecting the top 25 collaborators of Rüstem Nurten. A scholar is included among the top collaborators of Rüstem Nurten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rüstem Nurten. Rüstem Nurten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coşkun, Özlem, Senem Karabulut, Kürşat Serin, et al.. (2014). Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer. Tumor Biology. 35(6). 5575–5582. 4 indexed citations
2.
Albeniz, İşıl, et al.. (2014). Characterization of Lin−ALDHbright population using Ehrlich ascites tumor cells in mice. Tumor Biology. 35(10). 10363–10373. 1 indexed citations
3.
Nurten, Rüstem, et al.. (2014). K562 cells display different vulnerability to H2O2 induced oxidative stress in differing cell cycle phases. Cell Biology International. 39(2). 201–209. 5 indexed citations
4.
Ünlü, Ayhan, et al.. (2012). The interaction between actin and FA fragment of diphtheria toxin. Molecular Biology Reports. 40(4). 3135–3145. 3 indexed citations
5.
Albeniz, İşıl, et al.. (2011). CD38 expression as response of hematopoietic system to cancer. Oncology Letters. 2(4). 659–664. 5 indexed citations
6.
Hacıosmanoğlu, Ebru, et al.. (2011). On diphtheria toxin fragment A release into the cytosol—Cytochalasin D effect and involvement of actin filaments and eukaryotic elongation factor 2. The International Journal of Biochemistry & Cell Biology. 43(9). 1365–1372. 10 indexed citations
7.
Nurten, Rüstem, et al.. (2011). The cytotoxic effect of diphtheria toxin on the actin cytoskeleton. Cellular & Molecular Biology Letters. 17(1). 49–61. 9 indexed citations
8.
Nurten, Rüstem, et al.. (2009). Interaction of diphtheria toxin (fragment A) with actin. Cell Biochemistry and Function. 27(7). 430–439. 10 indexed citations
9.
Albeniz, İşıl, et al.. (2007). Erythrocyte CD38 as a prognostic marker in cancer. Hematology. 12(5). 409–414. 21 indexed citations
10.
Nurten, Rüstem, et al.. (2005). Endogenous ADP‐ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions. Cell Biochemistry and Function. 24(4). 369–380. 14 indexed citations
11.
Nurten, Rüstem, et al.. (2004). Actin—an inhibitor of eukaryotic elongation factor activities. Biochemical and Biophysical Research Communications. 317(4). 1061–1066. 15 indexed citations
12.
Albeniz, İşıl, Özlem Demir, Rüstem Nurten, & Engin Bermek. (2004). NAD Glycohydrolase Activities and ADP-Ribose Uptake in Erythrocytes From Normal Subjects and Cancer Patients. Bioscience Reports. 24(1). 41–53. 9 indexed citations
13.
Nurten, Rüstem, et al.. (2004). Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2. The International Journal of Biochemistry & Cell Biology. 37(1). 91–99. 23 indexed citations
14.
Nurten, Rüstem, et al.. (1999). On the Mode of Inhibition of Eukaryotic Protein Synthesis by ADP‐Ribosylation of Elongation Factor 2. IUBMB Life. 48(5). 557–562. 1 indexed citations
15.
Nurten, Rüstem, et al.. (1998). Interactions of elongation factor 2 with the cytoskeleton and interference with DNase I binding to actin. European Journal of Biochemistry. 256(1). 142–147. 12 indexed citations
16.
Aydıner, Adnan, et al.. (1997). Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells. Journal of Cancer Research and Clinical Oncology. 123(2). 113–117. 8 indexed citations
17.
Albeniz, İşıl, Rüstem Nurten, & Engin Bermek. (1997). ADP-Ribosylation of Serum Proteins: Elevated Levels in Neoplastic Cases due to Altered NAD/ADP-Ribose Metabolism. Cancer Investigation. 15(3). 217–223. 5 indexed citations
18.
Albeniz, İşıl, Rüstem Nurten, & Engin Bermek. (1996). ADP-ribosylation of serum proteins: evaluation as a potential tumor marker. Cancer Letters. 108(2). 239–245. 5 indexed citations
19.
Nurten, Rüstem, et al.. (1994). Interactions of eukaryotic elongation factor 2 with actin: A possible link between protein synthetic machinery and cytoskeleton. FEBS Letters. 356(1). 89–93. 59 indexed citations
20.
Nurten, Rüstem, et al.. (1994). ADP-Ribosylation of Human Serum Proteins Promoted by Endogenous NAD Glycohydrolase Activity. Biochemical and Biophysical Research Communications. 200(1). 450–458. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jutta Will Breakdown of academic impact, for papers by Jan Pippel Breakdown of academic impact, for papers by Toshiaki Hosaka Breakdown of academic impact, for papers by Michele Fontaine Breakdown of academic impact, for papers by Jun Kuwahara Breakdown of academic impact, for papers by Patrycja A. Krawczyk Breakdown of academic impact, for papers by Hildegard I. D. Mack Breakdown of academic impact, for papers by Fergal O’Farrell Breakdown of academic impact, for papers by Clark C. Fjeld
Rankless by CCL
2026